CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 101 enrolled
Drug / intervention
Masimo INVSENSOR00073device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06334055
NCT06334055N/ACompleted

Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073

Masimo Corporation·interventional·Posted Mar 27, 2024·Updated Jul 10, 2025

In Brief

A clinical study evaluating Masimo INVSENSOR00073 for Healthy. Completed, enrolled 101 participants across 1 site.

Detailed Summary

The aim of the study is to validate the Mean Arterial Pressure (MAP) parameter of Masimo INVSENSOR00073 against the gold standard blood pressure measurements from the arterial line while subject undergo a blood pressure variation procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedMar 27, 2024
Enrollment StartMar 4, 2024
Primary CompletionNov 8, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.3 years ago

Interventions

Masimo INVSENSOR00073device

Noninvasive blood pressure monitor